
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10451934
[patent_doc_number] => 20150336948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Isotopically Labeled Biaryl Urea Compounds'
[patent_app_type] => utility
[patent_app_number] => 14/404208
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11057
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404208
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404208 | Isotopically Labeled Biaryl Urea Compounds | May 23, 2013 | Abandoned |
Array
(
[id] => 9081950
[patent_doc_number] => 20130267480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'NOVEL CRYSTALLINE FORMS OF TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE SODIUM SALT'
[patent_app_type] => utility
[patent_app_number] => 13/901724
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29873
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901724
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/901724 | Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt | May 23, 2013 | Issued |
Array
(
[id] => 10882576
[patent_doc_number] => 08906954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Selective inhibitors of histone deacetylase'
[patent_app_type] => utility
[patent_app_number] => 13/897582
[patent_app_country] => US
[patent_app_date] => 2013-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 65140
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897582
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/897582 | Selective inhibitors of histone deacetylase | May 19, 2013 | Issued |
Array
(
[id] => 9538418
[patent_doc_number] => 20140163065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'PREPARATION AND THERAPEUTIC APPLICATIONS OF (2S, 3R)-N-2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3-YL)-3,5-DIFLUOROBENZAMIDE'
[patent_app_type] => utility
[patent_app_number] => 13/893382
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 24164
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893382
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/893382 | Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide | May 13, 2013 | Issued |
Array
(
[id] => 9530210
[patent_doc_number] => 08754082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Antiviral drugs for treatment of Arenavirus infection'
[patent_app_type] => utility
[patent_app_number] => 13/890825
[patent_app_country] => US
[patent_app_date] => 2013-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14347
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13890825
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/890825 | Antiviral drugs for treatment of Arenavirus infection | May 8, 2013 | Issued |
Array
(
[id] => 9135584
[patent_doc_number] => 20130296299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/889618
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22283
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889618
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/889618 | Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors | May 7, 2013 | Issued |
Array
(
[id] => 9135587
[patent_doc_number] => 20130296302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => '1H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/887177
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52951
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887177
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/887177 | 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof | May 2, 2013 | Issued |
Array
(
[id] => 10209337
[patent_doc_number] => 20150094327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES'
[patent_app_type] => utility
[patent_app_number] => 14/397994
[patent_app_country] => US
[patent_app_date] => 2013-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26446
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397994
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/397994 | COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES | Apr 28, 2013 | Abandoned |
Array
(
[id] => 10202852
[patent_doc_number] => 20150087840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'Process for Manufacturing Naphthyridine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/397421
[patent_app_country] => US
[patent_app_date] => 2013-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16334
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397421
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/397421 | Process for manufacturing naphthyridine derivatives | Apr 25, 2013 | Issued |
Array
(
[id] => 10209318
[patent_doc_number] => 20150094306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'PYRROLOPYRIDINONE DERIVATIVES AS TTX-S BLOCKERS'
[patent_app_type] => utility
[patent_app_number] => 14/394532
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 163675
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394532
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/394532 | Pyrrolopyridinone derivatives as TTX-S blockers | Apr 24, 2013 | Issued |
Array
(
[id] => 10220563
[patent_doc_number] => 20150105557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'INTERMEDIATES AND PROCESSES FOR PREPARING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/396346
[patent_app_country] => US
[patent_app_date] => 2013-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9519
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396346
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/396346 | Intermediates and processes for preparing compounds | Apr 21, 2013 | Issued |
Array
(
[id] => 9711068
[patent_doc_number] => 08835638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => '1,3-Oxathiolane derivatives, process for the preparation of 1,3-Oxathiolane derivatives and intermediates thereof'
[patent_app_type] => utility
[patent_app_number] => 13/861567
[patent_app_country] => US
[patent_app_date] => 2013-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7506
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13861567
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/861567 | 1,3-Oxathiolane derivatives, process for the preparation of 1,3-Oxathiolane derivatives and intermediates thereof | Apr 11, 2013 | Issued |
Array
(
[id] => 9786388
[patent_doc_number] => 20140303207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments'
[patent_app_type] => utility
[patent_app_number] => 13/856431
[patent_app_country] => US
[patent_app_date] => 2013-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39210
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13856431
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/856431 | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments | Apr 2, 2013 | Issued |
Array
(
[id] => 9004451
[patent_doc_number] => 20130225576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => '1H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/855874
[patent_app_country] => US
[patent_app_date] => 2013-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24795
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855874
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/855874 | 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof | Apr 2, 2013 | Issued |
Array
(
[id] => 10587643
[patent_doc_number] => 09309245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Beta-lactamase inhibitor compounds'
[patent_app_type] => utility
[patent_app_number] => 14/389854
[patent_app_country] => US
[patent_app_date] => 2013-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77130
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389854
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389854 | Beta-lactamase inhibitor compounds | Apr 1, 2013 | Issued |
Array
(
[id] => 9910144
[patent_doc_number] => 20150065343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'Acrylamide compounds for combating invertebrate pests'
[patent_app_type] => utility
[patent_app_number] => 14/389120
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73729
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389120
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389120 | Acrylamide compounds for combating invertebrate pests | Mar 27, 2013 | Abandoned |
Array
(
[id] => 9971368
[patent_doc_number] => 09018379
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-04-28
[patent_title] => 'Process of preparing solifenacin or salt thereof, and novel intermediate used in the process'
[patent_app_type] => utility
[patent_app_number] => 14/382529
[patent_app_country] => US
[patent_app_date] => 2013-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7510
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382529
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382529 | Process of preparing solifenacin or salt thereof, and novel intermediate used in the process | Mar 20, 2013 | Issued |
Array
(
[id] => 9757342
[patent_doc_number] => 20140288043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'PYRAZOLOPYRIDINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/847409
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847409
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/847409 | PYRAZOLOPYRIDINE COMPOUNDS | Mar 18, 2013 | Abandoned |
Array
(
[id] => 9401790
[patent_doc_number] => 08691841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/838088
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54009
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/838088 | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof | Mar 14, 2013 | Issued |
Array
(
[id] => 9042404
[patent_doc_number] => 20130245042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'Positive Allosteric Modulators of MGLUR2'
[patent_app_type] => utility
[patent_app_number] => 13/826760
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23439
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826760
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/826760 | Positive allosteric modulators of mGluR2 | Mar 13, 2013 | Issued |